Surgeon Perceptions and Experiences with Postoperative Acute Pain Management: A Mixed-Methods Study Authors: Vinod Dasa, Scott J. Keating, Sushanth Jeyakumar, K. D. Jacobs, Lauren A. Crowder, Sloan Rucker, Alexandra J. Feld, Moeen Panni, Ann M. Menzie Published: 2026 ABSTRACT IntroductionAlthough prior studies have examined healthcare providers’ perspectives on opioid prescribing for postoperative pain, limited research exists on surgeons’ experiences managing acute postoperative pain in adults. This study evaluated surgeons’ perceptions and experiences to better understand challenges in managing acute pain and assess perceived impacts of inadequately managed pain on patients.MethodsA sequential mixed methods study was conducted using concept elicitation interviews and a descriptive quantitative survey, with a convenience sample of United States (US)-based general, orthopedic, and plastic surgeons. Interview findings identified key themes related to surgeons’ perceptions of challenges and barriers associated with managing postoperative acute pain. These themes informed the development of a survey to quantify surgeons’ unmet needs, challenges, and experiences regarding postoperative pain management.ResultsKey themes from the interviews (N = 30) included challenges with effective pain management, advantages and disadvantages of commonly used pain medications, and difficulties managing pain in special populations. Among surveyed surgeons (N = 80), the most frequently reported challenges were managing patient pain management expectations (72.5%) and balancing adequate analgesic effect with risk of adverse events (71.3%). Approximately half (53.8%) were “moderately satisfied” with pain medications available during the study period, identifying the most important medication characteristics as the degree and duration of analgesic effect and time to onset. Most surgeons (80.0%) reported that concerns about opioid addiction or dependency “moderately” to “extremely impacted” their prescribing patterns. Additionally, 65% of surgeons indicated that inadequately managed postoperative pain has a moderate to extreme impact on patient recovery.ConclusionsSurgeon experiences with postoperative pain management emphasize challenges and unmet needs surrounding acute pain medications and highlight surgeons’ perceptions of the negative impacts of inadequately managed acute pain on patients. Key Summary Points Why carry out this study? Postoperative acute pain is common and frequently suboptimally controlled, and may be associated with delayed recovery, prolonged opioid use, increased healthcare utilization, and reduced patient functioning and quality of life.Although postoperative pain management is multidisciplinary, surgeons play a central role in perioperative care and discharge prescribing; however, limited quantitative evidence exists describing surgeons’ contemporary experiences, challenges, and perspectives regarding postoperative acute pain management.This study examined surgeons’ perceptions and experiences in managing postoperative acute pain, including their self-reported approaches to pain management, challenges and barriers encountered, and surgeon-perceived impacts of inadequately managed postoperative pain on patients. What was learned from the study? Participating surgeons reported that managing postoperative acute pain involved balancing analgesic effectiveness with safety risks, patient expectations, and administrative demands, and many described only moderate satisfaction with available prescription pain management options.Surgeons described widespread use of multimodal analgesia strategies to reduce reliance on opioids; however, they perceived analgesic options available during the study period often required tradeoffs between effectiveness and safety, as well as tolerability and patient-specific contraindications. As a result, surgeons reported a need to frequently individualize treatment decisions and balance competing considerations when selecting postoperative pain management approaches. Why carry out this study? Postoperative acute pain is common and frequently suboptimally controlled, and may be associated with delayed recovery, prolonged opioid use, increased healthcare utilization, and reduced patient functioning and quality of life.Although postoperative pain management is multidisciplinary, surgeons play a central role in perioperative care and discharge prescribing; however, limited quantitative evidence exists describing surgeons’ contemporary experiences, challenges, and perspectives regarding postoperative acute pain management.This study examined surgeons’ perceptions and experiences in managing postoperative acute pain, including their self-reported approaches to pain management, challenges and barriers encountered, and surgeon-perceived impacts of inadequately managed postoperative pain on patients. What was learned from the study? Participating surgeons reported that managing postoperative acute pain involved balancing analgesic effectiveness with safety risks, patient expectations, and administrative demands, and many described only moderate satisfaction with available prescription pain management options.Surgeons described widespread use of multimodal analgesia strategies to reduce reliance on opioids; however, they perceived analgesic options available during the study period often required tradeoffs between effectiveness and safety, as well as tolerability and patient-specific contraindications. As a result, surgeons reported a need to frequently individualize treatment decisions and balance competing considerations when selecting postoperative pain management approaches. Introduction Approximately 64 million surgical procedures are conducted in the United States (US) annually [1]. Postoperative acute pain is common, with nearly 86% of patients reporting postoperative pain and up to 75% of whom experienced moderate-to-severe pain [2]. A 2023 meta-analysis further reported that as many as 58% of postoperative patients experience moderate-to-severe acute pain lasting at least 1–2 weeks following hospital discharge [3]. While some degree of discomfort is expected during recovery, postoperative acute pain is frequently suboptimally controlled [4]. Inadequately managed postoperative pain, defined as persistent moderate-to-extreme pain following surgery that is not effectively controlled by treatment, may be associated with prolonged opioid use, increased morbidity, delayed recovery, decreased quality of life (QoL), and greater healthcare resource utilization and costs [4]. Postoperative acute pain is managed using a range of pharmacologic and non-pharmacologic approaches. Common pharmacologic treatments include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and gabapentinoids [5]. Interventional and procedural approaches such as regional anesthesia, peripheral nerve blocks, epidural techniques, and trigger point injections may also be used. In addition, non-pharmacologic strategies, including physical modalities (e.g., heat or ice therapy), rehabilitation, and complementary approaches, are often incorporated into care plans. These diverse strategies are frequently integrated within multimodal analgesia frameworks, which combine treatments with differing mechanisms of action to optimize pain control while minimizing medication-related risks [6]. Multimodal analgesia is a cornerstone of enhanced recovery after surgery (ERAS) protocols, which aim to reduce opioid exposure, accelerate recovery, shorten hospital length of stay, and improve postoperative outcomes [5]. Despite advances in multimodal care, managing postoperative acute pain remains complex. Opioid and non-opioid analgesics are associated with adverse events (AEs), such as nausea, vomiting, ileus, and respiratory depression, while opioids uniquely carry risks of misuse, addiction, and dependence [7–9]. A US-based survey reported that 79% of patients treated for postoperative pain experienced at least one medication-related AE [2]. Clinicians may therefore face challenges balancing analgesic effectiveness with safety considerations [4–6]. Inadequately controlled postoperative acute pain has been associated with delayed recovery, impaired physical and mental functioning, sleep disturbances, reduced productivity, and diminished QoL [4, 11–13]. Poor pain control may also be associated with prolonged opioid use and increased risk of dependence and opioid use disorder, as well as the development of chronic postoperative pain [4, 14, 15]. In addition, inadequately managed pain may contribute to extended hospital stays, increased readmissions, and higher healthcare costs [6, 7]. Postoperative acute pain management is inherently multidisciplinary and may involve surgeons, anesthesiologists, regional anesthesia teams, pain specialists, nurses, rehabilitation providers, and other clinicians. However, surgeons play a central role across the perioperative continuum, including setting expectations with patients, prescribing discharge analgesics, monitoring recovery-related pain concerns, and addressing pain-related barriers to rehabilitation and return to function. Despite this important role, limited quantitative evidence exists describing surgeons’ contemporary experiences and perspectives regarding postoperative acute pain management. This study aimed to explore surgeons' perspectives and experiences regarding postoperative acute pain management. Specifically, the objectives were to (1) characterize surgeons’ self-reported approaches to postoperative acute pain management and the challenges and barriers they encounter, and (2) identify surgeon-perceived unmet needs and patient impacts associated with inadequately managed postoperative acute pain using qualitative and quantitative methods. Methods This exploratory sequential mixed methods study integrated qualitative and quantitative approaches to provide both depth and breadth of insight into surgeon experiences [16, 17]. Semi-structured qualitative interviews were first conducted to elicit themes related to postoperative acute pain management. Findings from the qualitative phase informed the development of a quantitative survey designed to measure the frequency and distribution of surgeon-reported experiences and perceptions. Surgeon Recruitment Eligible participants specialized in general, orthopedic, or plastic surgery, were actively involved in managing patients’ postoperative acute pain, and regularly performed major surgical procedures in an operating room setting. Surgeons were required to spend ≥ 50% of working hours in a clinical setting and/or performing clinical tasks to ensure inclusion of primarily patient-facing clinicians. Additional eligibility criteria included an active US medical license, ≥ 3 years of surgical experience following completion of a medical residency or fellowship program, an average caseload comprising ≥ 50% adult patients, and fluency in English. Surgeons were recruited through established physician panels and databases. The qualitative phase used purposive sampling to recruit up to 30 surgeons (ten per specialty) to ensure diversity of perspectives [18]. The quantitative phase aimed to recruit up to 80 surgeons with representation across specialties (i.e., general, orthopedic, and plastic surgeons; n = 20–30 per group) and soft demographic quotas for sex (≤ 80% male) and race and/or ethnicity (≤ 80% white) aligned with population-based demographic estimates [19–22]. Due to the sequential study design, recruitment efforts for the two phases were performed separately. Study Procedures Qualitative interviews were conducted in January and February 2024, and the quantitative survey was administered in August 2024. All study procedures were conducted in accordance with the ethical standard of the WCG Institutional Review Board (IRB) and the Helsinki Declaration of the World Medical Association. The qualitative study was reviewed by SCG IRB and determined exempt (#1365464). The quantitative study was reviewed and approved by WCG IRB (#1377343). Qualitative participants were provided with a study information sheet and gave verbal informed consent, including consent to audio recording and publication of de-identified findings, prior to interview initiation. Quantitative participants provided electronic informed consent prior to survey participation. Data from both phases were de-identified to protect participant privacy and confidentiality. Qualitative Phase Sixty-minute semi-structured interviews explored surgeons’ clinical background and experience (e.g., types and volume of surgical procedures and typical patient population), pain management approaches, perceived challenges, and perceptions of patient impacts associated with inadequate pain control. Open-ended questions allowed additional probing into different aspects of surgeons’ responses to encourage both elaboration and clarification when necessary. Audio-recordings of interviews were transcribed verbatim and coded using deductive and inductive approaches, addressing pre-identified concepts while capturing new concepts emerging from the data [23]. Two trained researchers independently coded an initial subset of transcripts to assess coding consistency. Discrepancies were reviewed and resolved through discussion until a consensus was reached. Concept saturation was evaluated by grouping interviews chronologically; no new major concepts emerged after the fourth of six sets, indicating adequate thematic coverage [24] and that the sample size was sufficient to meet the study objectives. Quantitative Phase Survey items were developed using themes identified in the qualitative phase. The instrument underwent internal multidisciplinary review to assess clinical relevance, clarity, and programming functionality prior to fielding. Formal pilot testing and cognitive interviews were not conducted. The online survey contained 50 items to quantify surgeons’ clinical practice characteristics, challenges in postoperative acute pain management, perceived patient impacts, and attitudes toward analgesic therapies. Surgeons were also asked to rank the importance of medication characteristics from “most important” (a value of 1) to “least important” (a value of 7). For other survey items, surgeons were presented with a specific medication type (e.g., NSAID, opioid) and asked to select their level of either concern around medication-related AEs or comfort prescribing the medication to specific comorbid patient populations. Response options consisted of the following Likert-scale: “not at all” (a value of 1); “slightly” (a value of 2); “moderately” (a value of 3); “very” (a value of 4); and “extremely” (a value of 5). Additional demographic and clinical characteristics were captured via eligibility screening to characterize surgical specialization, sex, and race/ethnicity. Survey responses were collected through a secure electronic data capture system. All survey items were required. Two respondents initiated but did not complete the survey and were excluded from the analysis. No item-level missing data were present among completed surveys. Analyses Qualitative interview data used thematic analysis to identify patterns in surgeon responses concerning the relevant and important elements of managing patients’ acute pain, including surgeons’ experiences managing acute pain in adults and perceptions of patient-experienced impacts related to inadequate pain management. Quantitative survey data were analyzed using descriptive statistics. Continuous variables were summarized using means, standard deviations (SD), medians, interquartile ranges (IQR), and ranges. Categorical variables were summarized using frequencies and percentages. Given that the study was not powered for statistical comparisons, inferential analyses, including statistical comparisons between subgroups, were not performed. Qualitative data were coded and analyzed using NVivo 14 (Lumivero, LLC., Denver, CO, USA), and quantitative analyses were conducted using SAS® (Version 9.4; SAS Institute Inc., Cary, NC, USA). Results Qualitative Phase Surgeon Characteristics A total of 30 surgeons participated in qualitative interviews; most surgeons (n = 29, 96.7%) were male and nearly three-quarters (n = 22, 73.3%) identified as white (Table 1). Surgeons had a median of 24.5 years (range 4.0–45.0 years) of experience performing surgical procedures in an operating room setting following completion of a residency or fellowship program and reported spending a median of 95.0% (range 70.0–100.0%) of their working hours in a clinical setting.Table 1Surgeon demographics and clinical practice characteristicsQualitative sample (N = 30)Quantitative sample (N = 80)Demographic characteristicsn (%)n (%)Surgical specialty General10 (33.3)29 (36.3) Orthopedic10 (33.3)27 (33.8) Plastic10 (33.3)24 (30.0)Sex Male29 (96.7)64 (80.0) Female1 (3.3)16 (20.0)Race or ethnicitya Asian3 (10.0)14 (17.5) Black or African American0 (0.0)3 (3.8) Middle Eastern or North African1 (3.3)1 (1.3) Native Hawaiian or Other Pacific Islander0 (0.0)1 (1.3) White22 (73.3)58 (72.5) Hispanic or Latino3 (10.0)3 (3.8) Prefer not to answer1 (3.3)2 (2.5)Geographic regiona Northeast11 (36.7)23 (28.8) Midwest6 (20.0)16 (20.0) South6 (20.0)29 (26.3) West7 (23.3)17 (21.3)Surgical experience and clinical characteristicsMedian (min–max)Median (min–max) Years of experience (post-residency/fellowship)24.5 (4.0–45.0)17.0 (3.0–40.0) Percentage of time spent in a clinical setting95.0 (70.0–100.0)97.0 (75.0–100.0) Percentage of adult surgical patients99.0 (75.0–100.0)95.0 (50.0–100.0)aGroups are not mutually exclusive unless otherwise specifiedmax maximum, min minimum Table 1Surgeon demographics and clinical practice characteristicsQualitative sample (N = 30)Quantitative sample (N = 80)Demographic characteristicsn (%)n (%)Surgical specialty General10 (33.3)29 (36.3) Orthopedic10 (33.3)27 (33.8) Plastic10 (33.3)24 (30.0)Sex Male29 (96.7)64 (80.0) Female1 (3.3)16 (20.0)Race or ethnicitya Asian3 (10.0)14 (17.5) Black or African American0 (0.0)3 (3.8) Middle Eastern or North African1 (3.3)1 (1.3) Native Hawaiian or Other Pacific Islander0 (0.0)1 (1.3) White22 (73.3)58 (72.5) Hispanic or Latino3 (10.0)3 (3.8) Prefer not to answer1 (3.3)2 (2.5)Geographic regiona Northeast11 (36.7)23 (28.8) Midwest6 (20.0)16 (20.0) South6 (20.0)29 (26.3) West7 (23.3)17 (21.3)Surgical experience and clinical characteristicsMedian (min–max)Median (min–max) Years of experience (post-residency/fellowship)24.5 (4.0–45.0)17.0 (3.0–40.0) Percentage of time spent in a clinical setting95.0 (70.0–100.0)97.0 (75.0–100.0) Percentage of adult surgical patients99.0 (75.0–100.0)95.0 (50.0–100.0)aGroups are not mutually exclusive unless otherwise specifiedmax maximum, min minimum Surgeon demographics and clinical practice characteristics aGroups are not mutually exclusive unless otherwise specified max maximum, min minimum Themes Identified During Concept Elicitation Table 2 includes representative quotes for each of the themes identified from surgeon interviews. Surgeons’ overall goals for postoperative acute pain management most frequently included achieving adequate pain control (i.e., patients considering pain to be “tolerable”), enabling patients to participate in rehabilitation or ambulation, and avoiding pain medication AEs.Table 2Illustrative quotes from surgeon interviewsThemeIllustrative quotesPostoperative pain management goals“Number one, make the patient comfortable or, at least to the point of they can tolerate the discomfort with reasonable degree.” (SU113, Plastic)“[The goal is]…[T]o allow [patients] to mobilize postoperatively and then try to avoid some of the side effects of the pain medications themselves.” (SU117, General)“…[W]ith orthopedics, where getting up and getting ‘em moving is key, you don't want ‘em so sedated, and also the ability to ambulate, get out of bed, move their arms and legs ‘cause lying in bed just breeds complications.” (SU107, Orthopedic)Challenging patient populations“[T]hose who are not opiate naïve—those who have conditions that require repeat surgeries. Those who seem unreliable or kind of demanding in exactly what kind of regimen they want, and if they have a history of addiction or other substance abuse—those are the ones that are a little bit more challenging, because then it's hard to interface with the patient to really see how they're percei[ving] —like, how, you know, if their pain score—reported pain score doesn't match their clinical exam or—or their behavior—observed behavior, and then it's—that gets challenging.” (SU118, General)“Certainly, in a chronic pain patient…Those are always the ones that I’m most concerned about ‘cause they have a history of requiring—either stronger pain medication—a greater volume of pain medication than the average patient—or they struggle to get off the pain medication” (SU101, Orthopedic)Medication advantages and disadvantages“Well the narcotics are good ‘cause they make, they do take away pain, but they can drive ileus and they can increase length of stay… if you overdose on something, if you overdose somebody, which I see once every 2 or 3 years, that obviously has its own dangers…” (SU111, General)“[I]f you don’t want to feel the pain that’s fine, that’s what a narcotic does, makes you where you can’t comprehend the pain, it doesn’t address the problem, it doesn’t reduce inflammation, it just masks the pain.” (SU109, Orthopedic)“…anti-inflammatories can also help significantly with the pain, especially in orthopedic settings, because it’s anti-inflammatory, but again, you can have the stomach irritation. If they’re on any blood thinners, that can make them at risk for GI bleeds, and other bleeding. So, you have to kind of balance that and be judicious about your use of anti-inflammatory medications.” (SU102, Orthopedic)Challenges and barriers to postoperative pain management“[I]f there are comorbid conditions, their medical history, their previous medication experience, what they can tolerate, and then the insurance hurdles that can come up… I think you take each patient as it comes. Some patients are very simple straightforward, and others are more complicated, and depending on their history, their insurance, their medical conditions.” (SU102, Orthopedic)“[A] lot of patients believe that we’re capable of providing a completely pain-free experience, and sometimes it’s hard to communicate to patients that it’s not going to be pain-free.” (SU108, Orthopedic)“I think the biggest challenge is the balance of efficacy and side effects. So, the most potent and effective medications are intravenous narcotics, but their side effects and the ability to deliver them easily at home obviously creates a hurdle. So, then we switch to the next thing, which is oral narcotics. They don't kick in quite as fast. They last much longer, but they have a slew of side effects. So, you always try to just balance risk— pros and cons. A lot of management, just pros and cons: how much do you get for what the price the patient pays?” (SU110, General)Opioid prescribing administrative factors and considerations“[T]hey’re very cumbersome… You’ve got to have somebody check the database and the laws get modified. It seems like at every legislative session… at first, we had to have somebody check the database before we prescribed narcotics to a naïve patient – a patient naïve to us. [A]nd then I believe it changed and you’ve got to check it every time that you are going to prescribe a narcotic. And then they changed it again and said, ‘well, only a physician can do it, or one person that is delegated’ has to go through some kind of educational course that will be assigned and authorized to check the database. And then you’ve got to go and change your password or something every so often. So, keeping track of all those things is very cumbersome… And I seem to always get it wrong.” (SU113, Plastic)“I've had some patients who are on chronic pain medications, and the pharmacy would not release the newly prescribed opiates to—for the postoperative acute pain and I've had to find time to call these pharmacists and explain the situation, and it just requires more effort and energy and time, that I really kind of can’t lend.” (SU118, General)Opioid prescribing comfort/prescribing concern“I’m comfortable doing it— I do what needs to be done to control their pain and get ‘em rehab and recuperated…[B]ut I’m very strict on how long, how much, and it’s not something they’re gonna go on for many weeks and months…They know that and I tell ‘em beforehand that—And I do not feel comfortable with chronic narcotics for long periods of time ‘cause then you create another problem.” (SU117, Orthopedic)“I’m not prescribing enough to get them addicted…If I find that they keep asking me for more and more, I’ll get other health care professionals involved to solve that problem or I’m aware of it already ‘cause they’ve had pain management involved because of other prior chronic issues. So, you’re sort of on your toes, you know what to expect.” (SU128, Plastic)Surgeon-perceived patient impacts associated with inadequately managed postoperative pain“Well, the biggest issue I think will be a timeline factor that most people are expecting pain after a major operation for some period of time, but the longer it goes on, the more frustrated they become and certainly some would like to be completely pain-controlled to resume all their activities immediately, and others are willing to tolerate it for a longer period of time. But the longer it goes, again, the more frustration and disappointed or anxious they get about still being in pain after a procedure, or for any condition, I think.” (SU119, General)“[Inadequately managed pain] also delays their recovery, their perceived recovery, and return to work, and regular activities and-and other responsibilities they have such as, like, you know, family or other obligations.” (SU118, General)GI gastrointestinal Table 2Illustrative quotes from surgeon interviewsThemeIllustrative quotesPostoperative pain management goals“Number one, make the patient comfortable or, at least to the point of they can tolerate the discomfort with reasonable degree.” (SU113, Plastic)“[The goal is]…[T]o allow [patients] to mobilize postoperatively and then try to avoid some of the side effects of the pain medications themselves.” (SU117, General)“…[W]ith orthopedics, where getting up and getting ‘em moving is key, you don't want ‘em so sedated, and also the ability to ambulate, get out of bed, move their arms and legs ‘cause lying in bed just breeds complications.” (SU107, Orthopedic)Challenging patient populations“[T]hose who are not opiate naïve—those who have conditions that require repeat surgeries. Those who seem unreliable or kind of demanding in exactly what kind of regimen they want, and if they have a history of addiction or other substance abuse—those are the ones that are a little bit more challenging, because then it's hard to interface with the patient to really see how they're percei[ving] —like, how, you know, if their pain score—reported pain score doesn't match their clinical exam or—or their behavior—observed behavior, and then it's—that gets challenging.” (SU118, General)“Certainly, in a chronic pain patient…Those are always the ones that I’m most concerned about ‘cause they have a history of requiring—either stronger pain medication—a greater volume of pain medication than the average patient—or they struggle to get off the pain medication” (SU101, Orthopedic)Medication advantages and disadvantages“Well the narcotics are good ‘cause they make, they do take away pain, but they can drive ileus and they can increase length of stay… if you overdose on something, if you overdose somebody, which I see once every 2 or 3 years, that obviously has its own dangers…” (SU111, General)“[I]f you don’t want to feel the pain that’s fine, that’s what a narcotic does, makes you where you can’t comprehend the pain, it doesn’t address the problem, it doesn’t reduce inflammation, it just masks the pain.” (SU109, Orthopedic)“…anti-inflammatories can also help significantly with the pain, especially in orthopedic settings, because it’s anti-inflammatory, but again, you can have the stomach irritation. If they’re on any blood thinners, that can make them at risk for GI bleeds, and other bleeding. So, you have to kind of balance that and be judicious about your use of anti-inflammatory medications.” (SU102, Orthopedic)Challenges and barriers to postoperative pain management“[I]f there are comorbid conditions, their medical history, their previous medication experience, what they can tolerate, and then the insurance hurdles that can come up… I think you take each patient as it comes. Some patients are very simple straightforward, and others are more complicated, and depending on their history, their insurance, their medical conditions.” (SU102, Orthopedic)“[A] lot of patients believe that we’re capable of providing a completely pain-free experience, and sometimes it’s hard to communicate to patients that it’s not going to be pain-free.” (SU108, Orthopedic)“I think the biggest challenge is the balance of efficacy and side effects. So, the most potent and effective medications are intravenous narcotics, but their side effects and the ability to deliver them easily at home obviously creates a hurdle. So, then we switch to the next thing, which is oral narcotics. They don't kick in quite as fast. They last much longer, but they have a slew of side effects. So, you always try to just balance risk— pros and cons. A lot of management, just pros and cons: how much do you get for what the price the patient pays?” (SU110, General)Opioid prescribing administrative factors and considerations“[T]hey’re very cumbersome… You’ve got to have somebody check the database and the laws get modified. It seems like at every legislative session… at first, we had to have somebody check the database before we prescribed narcotics to a naïve patient – a patient naïve to us. [A]nd then I believe it changed and you’ve got to check it every time that you are going to prescribe a narcotic. And then they changed it again and said, ‘well, only a physician can do it, or one person that is delegated’ has to go through some kind of educational course that will be assigned and authorized to check the database. And then you’ve got to go and change your password or something every so often. So, keeping track of all those things is very cumbersome… And I seem to always get it wrong.” (SU113, Plastic)“I've had some patients who are on chronic pain medications, and the pharmacy would not release the newly prescribed opiates to—for the postoperative acute pain and I've had to find time to call these pharmacists and explain the situation, and it just requires more effort and energy and time, that I really kind of can’t lend.” (SU118, General)Opioid prescribing comfort/prescribing concern“I’m comfortable doing it— I do what needs to be done to control their pain and get ‘em rehab and recuperated…[B]ut I’m very strict on how long, how much, and it’s not something they’re gonna go on for many weeks and months…They know that and I tell ‘em beforehand that—And I do not feel comfortable with chronic narcotics for long periods of time ‘cause then you create another problem.” (SU117, Orthopedic)“I’m not prescribing enough to get them addicted…If I find that they keep asking me for more and more, I’ll get other health care professionals involved to solve that problem or I’m aware of it already ‘cause they’ve had pain management involved because of other prior chronic issues. So, you’re sort of on your toes, you know what to expect.” (SU128, Plastic)Surgeon-perceived patient impacts associated with inadequately managed postoperative pain“Well, the biggest issue I think will be a timeline factor that most people are expecting pain after a major operation for some period of time, but the longer it goes on, the more frustrated they become and certainly some would like to be completely pain-controlled to resume all their activities immediately, and others are willing to tolerate it for a longer period of time. But the longer it goes, again, the more frustration and disappointed or anxious they get about still being in pain after a procedure, or for any condition, I think.” (SU119, General)“[Inadequately managed pain] also delays their recovery, their perceived recovery, and return to work, and regular activities and-and other responsibilities they have such as, like, you know, family or other obligations.” (SU118, General)GI gastrointestinal Illustrative quotes from surgeon interviews GI gastrointestinal Advantages and Disadvantages of Acute Pain Medications Surgeons outlined their perceptions of the advantages and disadvantages of commonly used prescription acute pain medications available during the study period, including opioids, NSAIDs, and acetaminophen (Table 3). The most frequently reported advantage of opioid medications in postoperative acute pain management was analgesic effectiveness. In contrast, the most commonly reported disadvantage of opioids was the potential for AEs, which was spontaneously reported by 24 (80.0%) surgeons. AEs of concern included constipation or paralytic ileus, drowsiness, sedation or altered cognition, nausea, vomiting, and respiratory depression or overdose. When describing NSAIDs, the most identified advantage was reduced pain and inflammation, and surgeons valued NSAIDs as a non-opioid, non-addictive treatment option. Risk of potential AEs was a commonly reported disadvantage of NSAIDs, most often including gastrointestinal (GI) upset, gastric bleeding, renal failure, and increased bleed risk. Surgeons also described prescribing limitations for at-risk patient populations, such as patients with renal or cardiac conditions.Table 3Qualitative interviews: Pain medication advantages and disadvantagesa,bn (%)Opioid medicationsAdvantages13 (43.3) Effective analgesic12 (40.0) Safety (e.g., short-term safety)2 (6.7)Disadvantages26 (86.7) Risk of AEs24 (80.0) Opioid habitation or misuse13 (43.3) Prescribing to at-risk populations5 (16.7) Insufficient analgesic effect2 (6.7)NSAIDsAdvantages13 (43.3) Reduction of pain and inflammation9 (30.0) Non-opioid or non-addictive medication option5 (16.7) Limited AEs3 (10.0)Disadvantages26 (86.7) Risk of AEs14 (46.7) Prescribing to at-risk patient populations8 (26.7) Comparatively mild analgesic effect4 (13.3) High cost2 (6.7) Medication interactions or allergies2 (6.7)AcetaminophenAdvantages7 (23.3) Non-addictive2 (6.7) Analgesic effect2 (6.7) Safety or tolerability2 (6.7)Disadvantages14 (46.7) Impact on liver or kidney function9 (30.0) High cost of IV administration4 (13.3) Less effective analgesic2 (6.7)aGroups are not mutually exclusivebQualitative findings are reported using a > 5.0% threshold (i.e., concepts reported by less than 5.0% of the qualitative sample are not presented)AEs adverse events, IV intravenous, NSAIDs non-steroidal anti-inflammatory drugs Table 3Qualitative interviews: Pain medication advantages and disadvantagesa,bn (%)Opioid medicationsAdvantages13 (43.3) Effective analgesic12 (40.0) Safety (e.g., short-term safety)2 (6.7)Disadvantages26 (86.7) Risk of AEs24 (80.0) Opioid habitation or misuse13 (43.3) Prescribing to at-risk populations5 (16.7) Insufficient analgesic effect2 (6.7)NSAIDsAdvantages13 (43.3) Reduction of pain and inflammation9 (30.0) Non-opioid or non-addictive medication option5 (16.7) Limited AEs3 (10.0)Disadvantages26 (86.7) Risk of AEs14 (46.7) Prescribing to at-risk patient populations8 (26.7) Comparatively mild analgesic effect4 (13.3) High cost2 (6.7) Medication interactions or allergies2 (6.7)AcetaminophenAdvantages7 (23.3) Non-addictive2 (6.7) Analgesic effect2 (6.7) Safety or tolerability2 (6.7)Disadvantages14 (46.7) Impact on liver or kidney function9 (30.0) High cost of IV administration4 (13.3) Less effective analgesic2 (6.7)aGroups are not mutually exclusivebQualitative findings are reported using a > 5.0% threshold (i.e., concepts reported by less than 5.0% of the qualitative sample are not presented)AEs adverse events, IV intravenous, NSAIDs non-steroidal anti-inflammatory drugs Qualitative interviews: Pain medication advantages and disadvantagesa,b aGroups are not mutually exclusive bQualitative findings are reported using a > 5.0% threshold (i.e., concepts reported by less than 5.0% of the qualitative sample are not presented) AEs adverse events, IV intravenous, NSAIDs non-steroidal anti-inflammatory drugs Lastly, reported advantages of acetaminophen included its characteristics as a non-addictive and modest analgesic treatment option, and its safety or tolerability by most patients. The most frequently described disadvantages of acetaminophen were negative impacts on liver or kidney function. Surgeons implemented several strategies to manage AEs associated with acute pain medications, including switching medications, prescribing supportive medications to reduce patient discomfort (e.g., laxatives and antiemetics), and discontinuing a prescription pain medication or reducing its dose. Surgeons most frequently cited ideal acute pain medication characteristics to be improved safety, tolerability, and high analgesic effectiveness, as well as treatments that are non-addictive, non-opioid, and inexpensive and/or included in insurance formularies. Opioid-specific Considerations Surgeons reported varying levels of comfort when prescribing opioid medications for acute pain management. While some described being comfortable prescribing opioids, others expressed that their comfort level varied or that they were comfortable prescribing within specified parameters, such as limiting medication quantity or dosage to mitigate the risk of patient dependence. Still, some surgeons indicated they were not concerned about the risk of opioid addiction due to their practices of prescribing short courses of opioids, coordinating with a pain specialist, or referencing state prescription drug monitoring programs (PDMPs). Surgeons described several administrative tasks associated with prescribing opioids, including the need to comply with governmental policies, pharmacy or medication stock considerations, facility policies or technical requirements, and insurance-related factors (Table 4). About half of surgeons in the sample found these administrative tasks burdensome.Table 4Qualitative interviews: Opioid prescribing administrative factors and considerationsa,bn (%)Governmental policies25 (83.3) State monitoring programs21 (70.0) ePrescriptions6 (20.0) Quantity limitations6 (20.0) DEA oversight5 (16.7)Pharmacy or medication stock considerations11 (36.7) Difficulty with pharmacist or pharmacy7 (23.3) Stock shortages6 (20.0)Facility policies6 (20.0) Prescription monitoring2 (6.7) Two-factor authentication2 (6.7)Insurance-related factors4 (13.3) Medication formulary and costs2 (6.7) Quantity limits2 (6.7)aGroups are not mutually exclusivebQualitative findings are reported using a > 5.0% threshold (i.e., concepts reported by less than 5.0% of the qualitative sample are not presented)DEA US Drug Enforcement Agency Table 4Qualitative interviews: Opioid prescribing administrative factors and considerationsa,bn (%)Governmental policies25 (83.3) State monitoring programs21 (70.0) ePrescriptions6 (20.0) Quantity limitations6 (20.0) DEA oversight5 (16.7)Pharmacy or medication stock considerations11 (36.7) Difficulty with pharmacist or pharmacy7 (23.3) Stock shortages6 (20.0)Facility policies6 (20.0) Prescription monitoring2 (6.7) Two-factor authentication2 (6.7)Insurance-related factors4 (13.3) Medication formulary and costs2 (6.7) Quantity limits2 (6.7)aGroups are not mutually exclusivebQualitative findings are reported using a > 5.0% threshold (i.e., concepts reported by less than 5.0% of the qualitative sample are not presented)DEA US Drug Enforcement Agency Qualitative interviews: Opioid prescribing administrative factors and considerationsa,b aGroups are not mutually exclusive bQualitative findings are reported using a > 5.0% threshold (i.e., concepts reported by less than 5.0% of the qualitative sample are not presented) DEA US Drug Enforcement Agency Challenges and Barriers to Managing Postoperative Acute Pain When asked about challenges and barriers to managing acute pain, surgeons most frequently identified aspects of pain management post-discharge (Table 5). With respect to medication-related challenges, some surgeons identified the common challenge of balancing pain relief with potential AEs. They cited multimodal analgesia as a strategy to achieve effective pain control while mitigating associated AEs. Another reported difficulty was managing postoperative pain in challenging populations, including patients experiencing chronic pain, opioid tolerance (i.e., habituation) or opioid addiction. Additional reported challenges included the need for individualized pain management care, patient compliance, and difficulty with clinical monitoring post-discharge. Lastly, medication costs and access were also described as potential challenges. Specifically, medication costs were cited as a barrier for brand-name or novel medications, including specific medications like liposomal bupivacaine and intravenous (IV) Tylenol, and for patients who are uninsured or insured by Medicaid. For patients with other types of insurance, obtaining access was described as problematic when prescribing tapentadol, celecoxib, and certain forms of medication such as dissolvable versus swallowable anti-nausea medication.Table 5Qualitative interviews: Surgeon-reported challenges and barriers to postoperative pain managementa,bn (%)Pain management post-discharge24 (80.0) Patient compliance, monitoring, or clinical evaluation12 (40.0) Filling prescription pain medications (e.g., shortages, pharmacy issues)7 (23.3) Patient communication3 (10.0)Patient-related factors19 (63.3) Need for individualized pain management care13 (43.3) Patient or family expectations or medication preferences6 (20.0) Opioid habituation or misuse5 (16.7)Insurance- or cost-related factors17 (56.7) Medication cost11 (36.7) Insurance approval of medications10 (33.3)Facility or state policies and procedures12 (40.0) Medication formulary restrictions (e.g., facility formularies)7 (23.3) Medication quantity limits or prescribing restrictions4 (13.3) Writing or submitting medication prescriptions3 (10.0)Medication-related factors10 (33.3) Balancing pain relief with risk of AEs8 (26.7) Insufficient analgesic effects2 (6.7) Risk of addiction or dependence2 (6.7)aGroups are not mutually exclusivebQualitative findings are reported using a > 5.0% threshold (i.e., concepts reported by less than 5.0% of the qualitative sample are not presented)AEs adverse events Table 5Qualitative interviews: Surgeon-reported challenges and barriers to postoperative pain managementa,bn (%)Pain management post-discharge24 (80.0) Patient compliance, monitoring, or clinical evaluation12 (40.0) Filling prescription pain medications (e.g., shortages, pharmacy issues)7 (23.3) Patient communication3 (10.0)Patient-related factors19 (63.3) Need for individualized pain management care13 (43.3) Patient or family expectations or medication preferences6 (20.0) Opioid habituation or misuse5 (16.7)Insurance- or cost-related factors17 (56.7) Medication cost11 (36.7) Insurance approval of medications10 (33.3)Facility or state policies and procedures12 (40.0) Medication formulary restrictions (e.g., facility formularies)7 (23.3) Medication quantity limits or prescribing restrictions4 (13.3) Writing or submitting medication prescriptions3 (10.0)Medication-related factors10 (33.3) Balancing pain relief with risk of AEs8 (26.7) Insufficient analgesic effects2 (6.7) Risk of addiction or dependence2 (6.7)aGroups are not mutually exclusivebQualitative findings are reported using a > 5.0% threshold (i.e., concepts reported by less than 5.0% of the qualitative sample are not presented)AEs adverse events Qualitative interviews: Surgeon-reported challenges and barriers to postoperative pain managementa,b aGroups are not mutually exclusive bQualitative findings are reported using a > 5.0% threshold (i.e., concepts reported by less than 5.0% of the qualitative sample are not presented) AEs adverse events Surgeon-Perceived Impacts of Inadequate Postoperative Pain Management Nearly all surgeons described patient-related impacts associated with inadequately managed postoperative acute pain. Based on their clinical experience, participants indicated that insufficient pain control may negatively affect postoperative recovery, including delays in ambulation and slower recovery. Surgeons also described perceived effects on patients’ physical and emotional functioning, including sleep disruption, reduced ability to perform activities of daily living, mood changes, and difficulty returning to work or normal productivity. These findings reflect surgeon-reported perceptions and clinical experiences rather than objectively measured patient outcomes. Quantitative Phase Surgeon Characteristics A total of 80 surgeons completed the survey, with comparable proportions specializing in general (n = 29, 36.3%), orthopedic (n = 27, 33.8%), and plastic surgery (n = 24, 30.0%). Most surgeons were male (n = 64, 80.0%) and white (n = 58, 72.5%). Surgeons were similarly distributed across US Census regions; the largest proportion reported practicing medicine in the South (n = 29, 36.3%). Following completion of a residency or fellowship, surgeons had a median of 17.0 years (range 3.0–40.0 years) of experience performing surgical procedures in an operating room-based setting (Table 1). Prescription Medication Considerations for Managing Postoperative Acute Pain Most surgeons (n = 68, 85.0%) reported either “often” or “always” using multimodal analgesia. More than half of surgeons (n = 43, 53.8%) indicated being “moderately satisfied” with prescription pain medications available during the study period to manage postoperative acute pain. Surgeon-reported ‘satisfaction’ was subjective and was not defined. When ranking analgesic medication characteristics, surgeons most frequently ranked the following as “most important”: degree of analgesic effect (n = 42, 52.5%), time to onset of analgesic effect (n = 13, 16.3%), and concerns about breakthrough pain (n = 11, 13.8%; Fig. 1). In contrast, use of acute pain medications in at-risk or comorbid populations (n = 32, 40.0%) and risk of medication dependency or addiction (n = 21, 26.3%) were most often ranked as “least important.”Fig. 1Quantitative survey: Ranked importance of medication characteristics in postoperative pain managementa. aSurvey item: “Please rank the following medication characteristics in order of importance when managing postoperative acute pain. Please select a number for each characteristic from 1 (most important) to 7 (least important).” bA lower mean value represents greater importance of medication characteristic. SD standard deviation Quantitative survey: Ranked importance of medication characteristics in postoperative pain managementa. aSurvey item: “Please rank the following medication characteristics in order of importance when managing postoperative acute pain. Please select a number for each characteristic from 1 (most important) to 7 (least important).” bA lower mean value represents greater importance of medication characteristic. SD standard deviation Opioid-specific Considerations Nearly two-thirds of surgeons (n = 53, 66.3%) reported being either “very” or “extremely concerned” about opioid-related respiratory depression, and over one-third reported being either “very” or “extremely concerned” about confusion, dizziness, and drowsiness (n = 32, 40.0%) as well as nausea or vomiting (n = 29, 36.3%; Fig. 2). Nearly one-quarter (n = 19, 23.8%) reported being “not at all comfortable” prescribing opioids to patients with current or prior substance use behaviors (Fig. 3). Conversely, surgeons most often reported being “extremely comfortable” prescribing opioid medications to patients with no previous history of taking opioid medications (n = 30, 37.5%) and to patients with obesity (n = 17, 21.3%). Eighty percent of surgeons (n = 64) reported that their opioid prescribing preferences (e.g., limiting medication quantity and/or number of refills) were either “moderately,” “very,” or “extremely impacted” by the overall risk of opioid addiction or dependency.Fig. 2Quantitative survey: Opioid- and NSAID-associated AE prescribing concern. aA higher mean value represents a greater degree of concern about the associated adverse event. bSurvey item: “Please select your level of concern around the following adverse events or side effects associated with opioid medications.” cSurvey item: “Please select your level of concern around the following adverse events or side effects associated with non-steroidal anti-inflammatory drugs (NSAIDs).” AE adverse event, NSAIDs non-steroidal anti-inflammatory drugs, SD standard deviationFig. 3Quantitative survey: Opioid- and NSAID-associated prescribing comfort. aA lower mean value represents a lesser degree of medication prescribing comfort. bSurvey item: “How comfortable are you prescribing opioid medications to patients with:” cSurvey item: “How comfortable are you prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to patients with:”. NSAIDs non-steroidal anti-inflammatory drugs, SD standard deviation Quantitative survey: Opioid- and NSAID-associated AE prescribing concern. aA higher mean value represents a greater degree of concern about the associated adverse event. bSurvey item: “Please select your level of concern around the following adverse events or side effects associated with opioid medications.” cSurvey item: “Please select your level of concern around the following adverse events or side effects associated with non-steroidal anti-inflammatory drugs (NSAIDs).” AE adverse event, NSAIDs non-steroidal anti-inflammatory drugs, SD standard deviation Quantitative survey: Opioid- and NSAID-associated prescribing comfort. aA lower mean value represents a lesser degree of medication prescribing comfort. bSurvey item: “How comfortable are you prescribing opioid medications to patients with:” cSurvey item: “How comfortable are you prescribing non-steroidal anti-inflammatory drugs (NSAIDs) to patients with:”. NSAIDs non-steroidal anti-inflammatory drugs, SD standard deviation Surgeons reported writing a median of 10.0 (IQR 5.0–18.0) opioid prescriptions per week to manage patients’ postoperative pain, including inpatient administration, discharge prescriptions, and refills. Surgeons indicated needing a median of 5.0 (IQR 2.5–10.0) minutes per opioid prescription to complete administrative tasks (e.g., entering electronic prescriptions, two-factor authentication requirements, reviewing prescription monitoring systems). NSAID-specific Considerations When considering NSAID-associated AEs, surgeons were either “very” or “extremely concerned” about GI bleeding or ulcers (n = 40, 50.0%) and renal involvement (n = 38, 47.5%; Fig. 2). Furthermore, when surgeons were asked to consider comfort with prescribing NSAIDs to patients from distinct patient populations with various comorbid conditions, surgeons most frequently reported being “not at all comfortable” prescribing to those with GI bleeding or ulcers (n = 33, 41.3%), kidney or liver disease (n = 17, 21.3%), and bleeding disorders or those on blood-thinning medications (n = 15, 18.8%; Fig. 3). Challenges and Barriers to Managing Postoperative Acute Pain When selecting challenges or barriers to postoperative acute pain management, surgeons most frequently identified addressing patient expectations related to postoperative pain management (n = 58, 72.5%) and balancing adequate analgesic effect with risk of AEs or side effects (n = 57, 71.3%; Table 6). These were also most frequently identified as the most burdensome challenges (balancing effect with risk: n = 23, 28.8%; addressing expectations: n = 20, 25.0%). Around half of surgeons (n = 41, 51.3%) reported being the “most concerned” with postoperative pain management during patients’ initial recovery period following discharge (i.e., < 48 h at home), while over one-third (n = 29, 36.3%) reported being “most concerned” during patients’ postoperative recovery prior to discharge (e.g., post-anesthesia care unit, postoperative recovery room).Table 6Quantitative survey: Challenges and barriers to postoperative pain managementChallenges and barriersaMost burdensomebn (%)n (%)Addressing patient expectations related to adequate postoperative pain management58 (72.5)20 (25.0)Balancing adequate analgesic effect with risk of adverse events or side effects57 (71.3)23 (28.8)Negative impacts on recovery due to inadequate postoperative pain management39 (48.8)4 (5.0)Negative impacts on recovery due to medication side effects37 (46.3)6 (7.5)Administrative tasks associated with prescribing opioid medicationsc32 (40.0)6 (7.5)Medication supply or pharmacy shortages25 (31.3)5 (6.3)Formulary, dosage, or quantity prescribing limitations/restrictions23 (28.8)1 (1.3)Patient insurance coverage and/or expected out-of-pocket costs21 (26.3)4 (5.0)Pharmacist reluctance or unwillingness to fill prescribed medications18 (22.5)5 (6.3)I experience different challenge(s) or barrier(s) than the options listed0 (0.0)I do not experience any burden associated with challenge(s) or barrier(s)4 (5.0)I do not experience any challenges or barriersd2 (2.5)2 (2.5)aSurvey item: “Which of the following challenges or barriers do you encounter when managing patients’ postoperative acute pain? Please select all that apply.” Responses are not mutually exclusive, except where specifically notedbSurvey item: “Please select the challenge or barrier that is most burdensome to you.” All responses are mutually exclusivecE.g., entering electronic prescriptions, two-factor authentication requirements, reviewing prescription monitoring systemsdThis response is mutually exclusive Table 6Quantitative survey: Challenges and barriers to postoperative pain managementChallenges and barriersaMost burdensomebn (%)n (%)Addressing patient expectations related to adequate postoperative pain management58 (72.5)20 (25.0)Balancing adequate analgesic effect with risk of adverse events or side effects57 (71.3)23 (28.8)Negative impacts on recovery due to inadequate postoperative pain management39 (48.8)4 (5.0)Negative impacts on recovery due to medication side effects37 (46.3)6 (7.5)Administrative tasks associated with prescribing opioid medicationsc32 (40.0)6 (7.5)Medication supply or pharmacy shortages25 (31.3)5 (6.3)Formulary, dosage, or quantity prescribing limitations/restrictions23 (28.8)1 (1.3)Patient insurance coverage and/or expected out-of-pocket costs21 (26.3)4 (5.0)Pharmacist reluctance or unwillingness to fill prescribed medications18 (22.5)5 (6.3)I experience different challenge(s) or barrier(s) than the options listed0 (0.0)I do not experience any burden associated with challenge(s) or barrier(s)4 (5.0)I do not experience any challenges or barriersd2 (2.5)2 (2.5)aSurvey item: “Which of the following challenges or barriers do you encounter when managing patients’ postoperative acute pain? Please select all that apply.” Responses are not mutually exclusive, except where specifically notedbSurvey item: “Please select the challenge or barrier that is most burdensome to you.” All responses are mutually exclusivecE.g., entering electronic prescriptions, two-factor authentication requirements, reviewing prescription monitoring systemsdThis response is mutually exclusive Quantitative survey: Challenges and barriers to postoperative pain management aSurvey item: “Which of the following challenges or barriers do you encounter when managing patients’ postoperative acute pain? Please select all that apply.” Responses are not mutually exclusive, except where specifically noted bSurvey item: “Please select the challenge or barrier that is most burdensome to you.” All responses are mutually exclusive cE.g., entering electronic prescriptions, two-factor authentication requirements, reviewing prescription monitoring systems dThis response is mutually exclusive Surgeon-Perceived Impacts of Inadequate Postoperative Pain Management Nearly two-thirds of surgeons (n = 52, 65.0%) reported perceiving “moderate” to “extreme” patient-related impacts associated with inadequately managed postoperative acute pain. Respondents indicated that insufficient pain control may negatively affect patients’ postoperative recovery, including delays in ambulation, extended hospitalization, and limited participation in physical therapy. Around half of surgeons (n = 38, 47.5%) perceived that patients were “moderately satisfied” with pain medication options available during the study period. Discussion This mixed-methods study provides surgeon-reported perspectives on the challenges of managing postoperative acute pain across diverse surgical specialties. Surgeons described postoperative pain management as a complex clinical responsibility requiring careful balancing of analgesic effectiveness, safety risks, patient expectations, and administrative demands. Across both qualitative and quantitative phases, participants reported frequent use of multimodal analgesia strategies, reflecting contemporary efforts to reduce reliance on opioids while optimizing pain control. Medication-Related Challenges and Trade-offs Surgeons identified substantial concerns regarding AEs associated with commonly used analgesics. Consistent with existing literature, opioids were valued for their analgesic effectiveness but raised significant safety concerns. In a systematic review by Wheeler et al. (2002), up to 30% of postoperative patients experienced GI AEs (e.g., nausea or vomiting), while central nervous system effects (e.g., somnolence, dizziness) and pruritus were also common [9]. Notably, less than 1% of patients experienced respiratory depression, yet this remained the most frequently cited concern among surgeons, with 66.3% reporting being “very” or “extremely concerned” about this AE. This disconnect between statistical frequency and clinical concern may reflect the severity and potential lethality of respiratory depression, influencing prescribing behavior even when the absolute risk is low. NSAIDs were similarly recognized for their anti-inflammatory and analgesic properties, yet prescribing was often limited by safety concerns in at-risk populations. Evidence indicates that NSAIDs are associated with upper GI complications and acute renal failure, particularly among patients with comorbidities [25–27]. Surgeons in this study reported being “not at all comfortable” prescribing NSAIDs to patients with GI bleeding or ulcers (41.3%), kidney or liver disease (21.3%), or bleeding disorders (18.8%). Although acetaminophen is commonly used and generally well tolerated, it has been found to provide only moderate analgesic efficacy compared with NSAIDs [28]. These findings underscore the challenges surgeons face in weighing the clinical benefits of available analgesics against the risks of potential AEs, particularly in medically complex patients. Multimodal Analgesia: Adoption and Limitations The widespread adoption of multimodal analgesia strategies, reported by 85.0% of surveyed surgeons as “often” or “always” used, reflects efforts to optimize pain control while minimizing reliance on any single medication class. Multimodal approaches are intended to limit opioid consumption and reduce opioid-related AEs while achieving adequate analgesia [10]. However, our findings suggest that even within multimodal frameworks, surgeons perceive limitations. Over half (53.8%) reported being only “moderately satisfied” with available prescription pain medications, and 71.3% identified balancing adequate analgesic effect with AE risk as a primary challenge. It is important to acknowledge that multimodal analgesia encompasses more than oral prescription medications. Regional anesthesia techniques, nerve blocks, and structured ERAS pathways represent critical components of comprehensive pain management strategies. While some surgeons in this study mentioned these modalities, they were not the primary focus of participant responses. The present study’s focus on oral prescription analgesics reflects the scope of our research and does not diminish the importance of technique-based and systems-level approaches to postoperative pain management. Potential complications associated with multimodal therapy, such as polypharmacy risks, drug-drug interactions, or the challenge of tailoring regimens to individual patient profiles, may contribute to suboptimal outcomes. Successfully implementing multimodal analgesia requires coordination across care teams, individualized patient assessments, and ongoing monitoring. Opioid-Specific Concerns: Addiction Risk and Administrative Burden Eighty percent of surveyed surgeons reported that their opioid prescribing preferences were “moderately” to “extremely impacted” by concerns about addiction or dependency, and 23.8% indicated being “not at all comfortable” prescribing opioids to patients with current or prior substance use behaviors. These findings reflect heightened awareness of the opioid crisis and the potential for even short-term prescriptions to contribute to long-term opioid use. A US Centers for Disease Control and Prevention (CDC) analysis by Shah et al. demonstrated that even brief opioid prescriptions are associated with increased risk of long-term use, underscoring the clinical rationale for cautious prescribing [29]. However, efforts to mitigate addiction risk through restrictive prescribing must be balanced against the need to provide adequate postoperative analgesia. Under-prescribing or premature discontinuation of opioids may result in inadequately managed pain, which carries risks for delayed recovery, chronic pain development, and diminished QoL [4]. Surgeons also described substantial administrative burdens associated with opioid prescribing, including compliance with PDMPs, drug enforcement agency oversight, electronic prescribing requirements, and two-factor authentication. Surveyed surgeons reported spending a median of 5.0 min per prescription on such tasks. With a median of ten opioid prescriptions per week, this equates to approximately 50 min weekly, or an estimated 43.3 h annually per surgeon. While this reflects individual-level burden, the cumulative effect across surgical departments and healthcare systems, where advanced practice providers and other prescribers also manage opioid prescriptions, may substantially reduce productivity and divert resources from direct patient care. It is important to note that these administrative challenges are largely specific to the US healthcare system. Regulatory frameworks, insurance policies, and prescribing monitoring requirements vary widely across countries, and the generalizability of these findings to non-US settings may be limited. Surgeon-Perceived Impacts of Inadequately Managed Pain Sixty-five percent of surgeons indicated that inadequately managed postoperative pain has a moderate to extreme impact on the recovery process, with delays in ambulation, extended hospitalization, and limited participation in physical therapy identified as key consequences. It is important to emphasize that these findings reflect surgeon perceptions rather than objective patient outcome data. Nevertheless, they align with evidence from the broader literature indicating that poorly controlled postoperative pain is associated with negative impacts on physical functioning, recovery trajectories, and health-related quality of life [4, 30]. Approximately half of surgeons (47.5%) also perceived that inadequately managed pain negatively impacts patients’ sleep, mental health, and ability to return to work. These multidimensional consequences underscore the clinical significance of effective pain management not only for immediate postoperative comfort but also for longer-term functional and psychosocial outcomes. The alignment between surgeon-reported perceptions and published evidence suggests that clinicians are attuned to the real-world impacts of pain on their patients, even in the absence of formal outcome measurements within routine clinical practice. However, these findings should not be interpreted as definitive evidence of causal relationships or generalized inadequacy of current pain management strategies. Rather, they highlight areas where surgeons perceive room for improvement and where targeted interventions, whether pharmacologic, procedural, organizational, or educational, may enhance patient outcomes. Patient Communication and Expectation Management Surgeons identified addressing patient expectations as a leading challenge (72.5%) and one of the most burdensome aspects of postoperative pain management (25.0%). Qualitative interviews revealed that some patients expect complete pain relief, while clinical reality often involves managing pain to tolerable levels rather than eliminating it entirely. Misalignment between patient expectations and achievable outcomes can lead to dissatisfaction and potentially increased analgesic demands. Effective preoperative counseling and shared decision-making are essential to establishing realistic expectations. However, time constraints, communication barriers, and variability in patient health literacy may limit the effectiveness of these conversations. Additionally, surgeons described challenges in assessing pain in patients whose self-reported pain scores appeared incongruent with clinical examination findings or observed behaviors. These complexities highlight the need for improved communication strategies, patient education tools, and potentially interdisciplinary involvement (e.g., pain specialists, psychologists) to support both patients and surgeons in navigating postoperative pain management. Heterogeneity Among Surgeons and the Need for Further Research While this study provides valuable insights into surgeon perspectives, the findings may not capture the full spectrum of variability in clinical practice. Surgeons varied by specialty (general, orthopedic, and plastic surgery), years of experience (range 3–45 years post-training), and geographic region; however, the descriptive analysis precluded formal subgroup comparisons. Surgical specialty, patient populations, institutional resources, and prescribing philosophies may meaningfully influence pain management approaches. For example, orthopedic surgeons managing major joint replacements may have different concerns regarding NSAIDs and regional anesthesia compared to plastic surgeons performing elective procedures. Similarly, surgeons in academic centers with dedicated acute pain services may have different experiences than those in community settings with fewer resources. Future research should explore these sources of heterogeneity through stratified analyses to better understand how context shapes pain management practices and to identify targeted strategies for addressing specialty-specific and setting-specific challenges. Limitations Several limitations should be considered when interpreting these findings. First, participation was voluntary and may reflect selection bias, as surgeons with a greater interest in pain management may have been more likely to enroll. Second, the sample was predominantly male and white, which may limit generalizability, although demographic distributions were broadly consistent with the US surgical workforce. All findings were based on self-reported perceptions and are subject to recall and response biases. The study did not include patient-level clinical outcomes; therefore, findings cannot determine the objective adequacy of pain management practices. However, the mixed-methods design enabled triangulation of in-depth qualitative insights with broader quantitative patterns. The study used descriptive analyses and was not powered to detect differences across specialties, regions, or practice settings. Postoperative pain care is multidisciplinary, yet this study focused exclusively on surgeons to address an identified evidence gap; perspectives from anesthesiologists, pain specialists, nurses, and rehabilitation providers were not captured. Finally, several identified challenges, particularly administrative burdens, are specific to the US healthcare system and may not generalize to international populations. Despite these limitations, the mixed-methods approach provides a comprehensive and contemporary characterization of surgeon-reported experiences in postoperative pain management. Conclusions This mixed-methods study reveals challenges that surgeons face when managing postoperative acute pain despite widespread adoption of multimodal analgesia. Key difficulties include balancing analgesic effectiveness with safety risks, aligning treatment with patient expectations, and navigating administrative requirements related to opioid prescribing. Surgeons perceive that inadequately controlled pain adversely affects recovery, mobility, participation in rehabilitation activities, sleep, and return to normal functioning, including work. Although perception-based, these findings align with broader clinical evidence highlighting the consequences of suboptimal pain control. Addressing these challenges will likely require multifaceted strategies, including the development of analgesics with improved safety and efficacy profiles, expanded access to regional anesthesia and ERAS-based approaches, streamlining prescribing workflows, and stronger multidisciplinary coordination. Continued efforts to optimize postoperative pain management may improve recovery trajectories and reduce the functional burden associated with acute postoperative pain.